Experience

MONTEFIORE NEW ROCHELLE HOSPITAL

• United States
• Hospitals and Health Care
• 1 - 100 Employee

• Internal Medicine Resident

  • Jun 2022 - Present



Octave

• United States
• Biotechnology Research
• 1 - 100 Employee

• Research And Development consultant

  • Jan 2022 - Present



Keck School of Medicine of the University of Southern California

• United States
• Higher Education
• 700 & Above Employee

• Graduate Research Assistant

  • Jun 2011 - May 2012

  Research targets two clinical problems 1) Wound Healing and 2) Tumor Progression. Wound healing is a physiological repair process by inflammatory, epithelial, fibroblastic and endothelial cells that is only activated in response to injury or a surgeons knife. Tumor progression is a similar process by a similar group of cells (called tumor stroma cells) in response to injury that is caused by invading tumor cells. Wound healing usually has a beginning and an ending, whereas tumor has a beginning but often an open ending (patient death) if left untreated. Therefore, tumors have been called "wounds that do not heal" (The New England Journal of Medicine, 315:1650-1659). This is how his laboratory discovered that the SECRETED form of heat shock protein-90alpha (eHsp90a) plays an important role in both wound healing and tumor progression. Understanding the mechanism of action by eHsp90a and targeting eHsp90a (not the intracellular chaperone Hsp90) as a new protein therapy (for wound healing) and for therapeutic inhibitors (against tumors) are the two main focus in Dr.Wei Li laboratory. Show less